StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BNET

Bion Environmental Technologies, Inc.

BNET OTC Agricultural Chemicals EDGAR ↗
$0.18
+0.03 +16.67%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$10.0M
Revenue (TTM) ⓘ
$0.00
Net income (TTM) ⓘ
-$1.96M
EPS (TTM) ⓘ
$-0.03
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
-$1.68M
Cash ⓘ
$3.67K
Total assets ⓘ
$35.6K
Gross margin ⓘ
—
52-week range ⓘ
$0.08 – $0.38

AI briefing

from the latest 10-K, 10-Q and 8-K events

Bion Environmental Technologies is a pre-revenue developer of waste-to-value technology for beef production, organic fertilizers, and clean fuels, currently under severe financial stress.

What they do

Bion is developing Gen3Tech and ARS (Ammonia Recovery System) platforms intended to convert livestock waste into low-carbon fertilizer and clean fuel feedstocks, with an initial demonstration facility at Fair Oaks. The company completed a technology demonstration and optimization at Fair Oaks but has not proceeded beyond that stage. It also markets an ammonia control solution to biogas operators and developers. The company is not currently generating any significant revenues.

Revenue drivers

  • Fertilizer products — Intended production of organic and low-carbon fertilizers from recovered ammonia and nutrients; no meaningful revenue reported in 2023, 2024, 2025, or recent quarters.
  • Ammonia control solution — Sales or licensing of ammonia control technology to biogas operators and developers; management cites strong recent interest but no disclosed revenue contribution.
  • Gen3Tech beef projects — Planned integrated beef production modules using sustainable technology; each module is projected to cost in excess of $50 million to construct, with no projects yet built or generating revenue.
  • ARS bolt-on projects — Standalone ammonia recovery system installations projected at $10–$40 million each; no such projects have been constructed or monetized.

Recent performance

Annual revenue was $0 in 2023 and 2024, and recent quarterly revenue was $0 for periods ending 2024-12-31, 2025-03-31, 2025-12-31, and 2026-03-31. Net income was $11.7 million in 2024 but swung to a loss of $2.4 million in 2025, with diluted EPS of $-0.04 in 2025 versus $-0.22 in 2024. Operating cash flow remained negative at approximately $-868,000 in 2025. As of 2026-03-31, total assets were $71,078, total liabilities were $6.7 million, and shareholder equity was negative $6.6 million.

Strategy

Since a new leadership team was installed in May 2024, the company has pursued a short-term funding strategy while seeking longer-term capital solutions, aiming to align with strategic partners. Management emphasizes the completed technology demonstration and optimization at Fair Oaks and initial responses from fertilizer outreach as recent successes. It also cites strong interest in its ammonia control solution from biogas operators and developers, who could supply feedstock. The company acknowledges that reaching its goals will require resolution of existing financial difficulties and access to very large amounts of equity and debt, as well as substantial personnel and technical resources it currently lacks.

Risks

  • Going concern and liquidity — The company has negative shareholder equity of $6.6 million, cash of only $43,553 at 2026-03-31, and no significant revenues, with management stating anticipated revenues will not meet needs for many years.
  • Inability to raise capital — Bion has faced extreme difficulty obtaining needed funding throughout fiscal 2024 and the first nine months of the current fiscal year, and each proposed project requires $10–$40 million or more.
  • Management instability and key-person risk — The company has experienced the death of a former COO/CEO, the resignation of a CEO effective May 31, 2024, and the retirement of its President/General Counsel/CFO effective July 31, 2024, leaving a small core management team.
  • Conflicts of interest with BLG loan group — The BLG loan group is controlled by two (or three, per the 10-Q) of Bion's directors and key management and holds a security position in the company's intellectual property, creating potential conflicts.

Outlook

Management states that it is pursuing short-term funding while seeking longer-term capital solutions, and that these efforts are ongoing. It believes the company, assuming it aligns with appropriate strategic partners and obtains sufficient financing, can exploit an opportunity at the intersection of agriculture, renewable energy, the environment, and consumer demand. However, management explicitly warns there is no assurance that the company will reach or approach its goals, and that doing so requires resolution of existing financial difficulties and access to very large amounts of capital. No specific revenue or earnings guidance is provided.

Recent SEC filings

40 most recent
Annual, quarterly & current reports